Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer -- Robinson et al. 95 (6): 2664 Data Supplement - Supplemental Data -- Journal of Clinical Endocrinology & Metabolism


Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer J Clin Endocrinol Metab Robinson et al. 95: 2664 Supplemental Data Supplemental Data Files in this Data Supplement: Supplemental Data - Figure 1